Marcaine Spinal (Bupivacaine Hydrochloride)

Marcaine Spinal is a local anesthetic used in regional anesthesia techniques.

• Spinal anesthesia for surgical procedures: produces a dense sensory block for operations on the lower abdomen, pelvis or lower limbs.
• Epidural anesthesia: provides segmental analgesia for labor, postoperative pain or chronic pain management.
• Infiltration anesthesia for pain control: delivers targeted numbness for minor surgical sites or postoperative wound infiltration.

• Bupivacaine Hydrochloride reversibly inhibits voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of action potentials. By stabilizing the neuronal membrane, it blocks nerve impulse transmission, resulting in loss of sensation and motor function in the targeted area without affecting consciousness.

Adverse reactions may occur following administration of Marcaine Spinal.

Common Side Effects

• Hypotension: reduced blood pressure due to sympathetic blockade.
• Bradycardia: slowed heart rate, especially with high spinal levels.
• Nausea or vomiting: gastrointestinal upset after regional block.
• Dizziness or light‑headedness: related to blood pressure changes.
• Injection site pain or irritation.
• Metallic taste: transient sensation after intrathecal injection.

Serious or Rare Side Effects

• Cardiac arrest or severe arrhythmias: potential cardiotoxicity at high plasma concentrations.
• Respiratory depression: impaired breathing due to high spinal block.
• Seizures: central nervous system toxicity from excessive dosing.
• Allergic reaction: rash, urticaria or anaphylaxis.
• Prolonged motor block: extended loss of muscle function.
• Spinal hematoma: rare bleeding complication in the epidural or subarachnoid space.

Careful assessment and monitoring are required when using Marcaine Spinal.

• Allergy assessment: confirm no known hypersensitivity to amide‑type local anesthetics.
• Cardiac evaluation: avoid in patients with significant conduction disorders or severe cardiac disease.
• Dose limitation: adhere to recommended maximum doses to reduce risk of systemic toxicity.
• Patient monitoring: continuously observe blood pressure, heart rate and respiratory status during and after injection.
• Neurological assessment: check for signs of high spinal block or prolonged motor impairment.
• Store at controlled room temperature: keep in the original container, protect from light and moisture.

Bupivacaine may interact with other agents that affect cardiac or central nervous system function.

Major Interactions (Avoid)

• Class I antiarrhythmic drugs (e.g., quinidine, procainamide): increase risk of cardiotoxicity.
• Beta‑adrenergic blockers: may potentiate bradycardia and hypotension.
• General anesthetics such as halothane: can enhance central nervous system depression.

Moderate Interactions (Monitor Closely)

• Opioids (e.g., morphine, fentanyl): may increase sedation and respiratory depression.
• Sedatives or benzodiazepines: require careful respiratory monitoring.
• Vasopressors (e.g., ephedrine): may mask hypotensive effects of the block.